4//SEC Filing
Vincent Mark D. 4
Accession 0001567619-22-001377
CIK 0000882361other
Filed
Jan 19, 7:00 PM ET
Accepted
Jan 20, 5:15 PM ET
Size
5.9 KB
Accession
0001567619-22-001377
Insider Transaction Report
Form 4
Vincent Mark D.
Director
Transactions
- Award
Director Stock Option (Right to Buy)
2022-01-18+50,000→ 50,000 totalExercise: $1.39Exp: 2032-01-17→ Common Shares (50,000 underlying)
Footnotes (2)
- [F1]Converted from Canadian exercise price of C$1.74 using an exchange rate of C$1.2529 = US$1.00.
- [F2]The options were granted on January 18, 2022, and vest as follows: 50% vest on January 18, 2023; 25% vest on January 18, 2024; and 25% vest on January 18, 2025.
Documents
Issuer
Aptose Biosciences Inc.
CIK 0000882361
Entity typeother
Related Parties
1- filerCIK 0001761243
Filing Metadata
- Form type
- 4
- Filed
- Jan 19, 7:00 PM ET
- Accepted
- Jan 20, 5:15 PM ET
- Size
- 5.9 KB